Pfizer (PFE) Total Liabilities (2016 - 2025)
Pfizer (PFE) has disclosed Total Liabilities for 17 consecutive years, with -$92.8 billion as the latest value for Q3 2025.
- On a quarterly basis, Total Liabilities fell 173.12% to -$92.8 billion in Q3 2025 year-over-year; TTM through Sep 2025 was -$92.8 billion, a 173.12% decrease, with the full-year FY2024 number at $124.5 billion, down 9.59% from a year prior.
- Total Liabilities was -$92.8 billion for Q3 2025 at Pfizer, down from $117.0 billion in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $137.7 billion in Q4 2023 to a low of -$101.2 billion in Q2 2023.
- A 5-year average of $65.2 billion and a median of $102.5 billion in 2022 define the central range for Total Liabilities.
- Peak YoY movement for Total Liabilities: skyrocketed 889.85% in 2022, then plummeted 200.08% in 2023.
- Pfizer's Total Liabilities stood at $104.0 billion in 2021, then dropped by 2.62% to $101.3 billion in 2022, then soared by 35.96% to $137.7 billion in 2023, then dropped by 9.59% to $124.5 billion in 2024, then crashed by 174.54% to -$92.8 billion in 2025.
- Per Business Quant, the three most recent readings for PFE's Total Liabilities are -$92.8 billion (Q3 2025), $117.0 billion (Q2 2025), and -$90.6 billion (Q1 2025).